Kindstar Globalgene Technology, Inc. (Kindstar Global) disclosed that it bought back 38,500 ordinary shares on 7 September 2026 through on-market transactions on the Hong Kong Stock Exchange.

The shares were repurchased within a price range of HKD 0.935–0.975, equivalent to an average cost of HKD 0.94 per share and an aggregate outlay of HKD 36,224.65. All repurchased shares are being retained as treasury stock; none have been cancelled.

Capital structure after the transaction • Issued shares (excluding treasury): 1,032.43 million, down 0.0037 % from 1,032.47 million before the buy-back. • Treasury shares: 8.90 million, up from 8.86 million. • Total issued shares (including treasury): unchanged at 1,041.33 million.

Repurchase mandate utilisation • Authorised under the 5 June 2026 mandate: 103.43 million shares. • Cumulative shares bought back under the mandate: 1.84 million, representing 0.18 % of the issued share base on the mandate date. • A 30-day moratorium on new share issues or treasury-share disposals extends through 7 October 2026.

The company affirmed that the repurchase complied with Hong Kong Main Board Rule 10.06 and confirmed no material changes to the explanatory statement filed on 24 April 2026.